Leadership Overview
Versiti has 11 executives leading key functions including strategy, finance, information technology, human resources, operations, and marketing.
Driven by a commitment to advancing blood health, Versiti provides innovative solutions in transfusion medicine, transplantation, and blood-related diseases, enhancing patient outcomes and healthcare system efficiencies nationwide.
Driven by a commitment to advancing blood health, Versiti provides innovative solutions in transfusion medicine, transplantation, and blood-related diseases, enhancing patient outcomes and healthcare system efficiencies nationwide.
Leadership Roles at Versiti
Jacqueline Fredrick - Chief Executive Officer
Jacqueline Fredrick, the Chief Executive Officer at Versiti, directs the organization's overarching strategy and operational execution. Fredrick's leadership focuses on advancing Versiti's mission to improve patient health and support healthcare partners through innovative solutions in transfusion medicine, transplantation, and blood-related diseases. This executive role involves steering the company's growth initiatives and ensuring alignment with national healthcare needs. The Chief Executive Officer's purview encompasses fostering a culture of innovation and operational excellence across all departments. Jacqueline Fredrick drives the strategic vision that underpins Versiti's commitment to enhanced patient outcomes and cost efficiencies for healthcare systems. This leadership position is central to Versiti's objective of becoming a national leader in blood health innovation.
Dennis Mestrich - President & Chief Executive Officer
Dennis Mestrich, the President & Chief Executive Officer at Versiti, guides the organization's strategic direction and operational framework. Mestrich's leadership emphasizes Versiti's mission to enhance patient health and empower healthcare partners through pioneering solutions in transfusion medicine, transplantation, and blood-related disorders. This executive capacity involves overseeing the company's expansion and ensuring its services meet evolving national healthcare demands. The President & Chief Executive Officer's responsibilities include cultivating an environment of continuous improvement and high performance throughout the enterprise. Dennis Mestrich champions the strategic imperatives that define Versiti's dedication to superior patient care and economic advantages for healthcare providers. This pivotal role solidifies Versiti's position as a frontrunner in blood health advancements.
Byron Buhner - President & Chief Executive Officer
Byron Buhner, the President & Chief Executive Officer at Versiti, spearheads the company's strategic initiatives and operational management. Buhner's executive focus centers on Versiti's core mission: improving patient well-being and bolstering the success of healthcare collaborators via advanced solutions in transfusion medicine, transplantation, and blood-related conditions. This leadership role is critical for directing the company's forward momentum and ensuring its offerings address the complex needs of the national healthcare landscape. The President & Chief Executive Officer's mandate includes fostering a culture of groundbreaking development and operational superiority. Byron Buhner propels the strategic vision that reinforces Versiti's commitment to superior patient results and financial benefits for healthcare networks. This executive position is fundamental to Versiti's objective of leading national blood health innovation.
Christopher Miskel - President & Chief Executive Officer
Christopher Miskel, the President & Chief Executive Officer at Versiti, leads the organization's strategic planning and execution. Miskel's executive purview involves advancing Versiti's mission to elevate patient health and ensure the success of its healthcare partners through cutting-edge solutions in transfusion medicine, transplantation, and blood-related diseases. This leadership position is vital for driving the company's growth trajectory and guaranteeing its services effectively address the demands of healthcare systems nationwide. The President & Chief Executive Officer's responsibilities extend to nurturing an environment of pioneering advancement and operational excellence. Christopher Miskel champions the strategic direction that solidifies Versiti's dedication to improved patient outcomes and economic advantages for healthcare providers. This executive role is paramount to Versiti's standing as a national leader in blood health innovation.
Terri Ainsworth - Chief Financial Officer
Terri Ainsworth, the Chief Financial Officer at Versiti, manages the organization's financial health and strategic fiscal planning. Ainsworth's leadership ensures robust financial operations that support Versiti's mission of improving patient outcomes and enabling healthcare partner success through innovative solutions in transfusion medicine, transplantation, and blood-related diseases. This executive role oversees all financial activities, including budgeting, forecasting, and resource allocation, to drive cost efficiencies and sustainable growth nationwide. The Chief Financial Officer's responsibilities extend to safeguarding the company's assets and optimizing financial performance. Terri Ainsworth directs the financial strategies that underpin Versiti's commitment to value-added services and fiscal responsibility, ensuring the organization's continued impact on patient care and healthcare systems.
Brian Bautista - Executive Vice President & Chief Operating Officer
Brian Bautista, the Executive Vice President & Chief Operating Officer at Versiti, directs the company's day-to-day operations and ensures seamless service delivery. Bautista's leadership is pivotal in executing Versiti's mission to enhance patient health and empower healthcare partners through value-added solutions in transfusion medicine, transplantation, and blood-related diseases. This executive role oversees operational efficiency, process optimization, and the effective deployment of resources across all functional areas nationwide. The Executive Vice President & Chief Operating Officer's responsibilities include driving operational excellence, managing supply chains, and ensuring compliance with industry standards. Brian Bautista leads the operational strategies that are essential for Versiti's success in achieving improved patient outcomes and cost efficiencies for healthcare systems, reinforcing the organization's commitment to innovation and quality.
Rodeina Davis - Chief Information Officer
Rodeina Davis, the Chief Information Officer at Versiti, directs the company's technology strategy and digital infrastructure. Davis's leadership ensures that Versiti's information systems effectively support its mission to improve patient health and empower healthcare partners through innovative solutions in transfusion medicine, transplantation, and blood-related diseases. This executive role oversees the development and implementation of secure, scalable technology platforms that enhance operational efficiency and data integrity nationwide. The Chief Information Officer's responsibilities include managing cybersecurity, driving digital transformation, and leveraging technology to achieve cost efficiencies. Rodeina Davis guides the technological advancements that are critical to Versiti's success in delivering value-added services and improving patient outcomes across healthcare systems.
James Weidner - Executive Vice President & Chief Human Resources Officer
James Weidner, the Executive Vice President & Chief Human Resources Officer at Versiti, leads the organization's human capital strategy and talent management initiatives. Weidner's executive focus is on cultivating a high-performing workforce that drives Versiti's mission to improve patient health and support its healthcare partners through innovative solutions in transfusion medicine, transplantation, and blood-related diseases. This leadership role oversees all aspects of human resources, including recruitment, employee development, compensation, and fostering a positive organizational culture nationwide. The Executive Vice President & Chief Human Resources Officer's responsibilities are crucial for attracting and retaining top talent, ensuring operational excellence, and promoting employee engagement. James Weidner directs the HR strategies that are fundamental to Versiti's ability to deliver exceptional patient care and achieve its strategic objectives.
Chrissy Schroeder - Executive Vice President & Chief Marketing Officer
Chrissy Schroeder, the Executive Vice President & Chief Marketing Officer at Versiti, leads the organization's brand strategy and market engagement initiatives. Schroeder's executive focus is on amplifying Versiti's mission to improve patient health and strengthen its healthcare partnerships through innovative communication of its solutions in transfusion medicine, transplantation, and blood-related diseases. This leadership role oversees all marketing and communications efforts, including brand development, digital marketing, and public relations, to enhance market presence and drive engagement nationwide. The Executive Vice President & Chief Marketing Officer's responsibilities are critical for articulating Versiti's value proposition and fostering strong relationships with stakeholders. Chrissy Schroeder directs the marketing strategies that are fundamental to Versiti's growth and its ability to effectively convey its impact on patient care and healthcare systems.
Lynne Briggs - Vice President & Chief Information Officer
Lynne Briggs, the Vice President & Chief Information Officer at Versiti, oversees the strategic direction and implementation of the organization's information technology infrastructure. Briggs's leadership ensures that Versiti's technological capabilities effectively support its mission to advance patient health and empower healthcare partners through innovative solutions in transfusion medicine, transplantation, and blood-related diseases. This executive role manages the development and maintenance of secure, reliable IT systems that enhance operational efficiency and data management nationwide. The Vice President & Chief Information Officer's responsibilities include driving technological innovation, ensuring data security, and optimizing IT resources to support Versiti's strategic objectives. Lynne Briggs guides the technological advancements critical for Versiti's delivery of value-added services and its contribution to improved patient outcomes and healthcare system efficiencies.
Explore Leadership Teams in Blood & Organ Banks
信达生物制药 specializes in the research, development, and production of innovative biopharmaceuticals. The company focuses on providing advanced therapies for various diseases, particularly in oncology and autoimmune disorders. Its intended clients include healthcare providers, hospitals, and patients seeking effective treatment options. With a commitment to quality and innovation, 信达生物制药 aims to improve patient outcomes through its cutting-edge products.
Company Leadership
HX
Serum Institute of India Pvt. Ltd., founded in 1966 and headquartered in Pune, India, is a manufacturer of immunobiological drugs including vaccines in India.
Company Leadership PD
MC
Bloodworks Northwest, founded in 1944 and headquartered in Seattle, Washington is a non- profit blood donation organization that collects, tests and distributes blood to hospitals throughout the Northwest.
Company Leadership BF
AS
RG
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax vaccine; CYFENDUS for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; and Raxibacumab injection for the treatment and prophylaxis of inhalational anthrax. It also provides ACAM2000, a smallpox vaccine; CNJ-016 to address complications from smallpox vaccination; TEMBEXA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; BAT for the treatment of symptomatic botulism; Ebanga for the treatment of Ebola; Reactive Skin Decontamination Lotion Kit to remove or neutralize chemical warfare agents from the skin; Trobigard, a atropine sulfate obidoxime chloride auto-injector. In addition, the company is developing CGRD-001 for the treatment of poisoning by organophosphorus nerve agents or organophosphorus compounds; EBS-LASV to prevent Lassa fever; EBS-MARV to prevent Marburg virus disease; EBS-SUDV to prevent Sudan virus disease; Pan-Ebola mAbs for the treatment of ebola virus; SIAN Antidote for initial treatment of certain or suspected acute cyanide poisoning; UniFlu for immunity against influenza A and B viruses; and WEVEE-VLP for equine encephalitis virus infections. Further, it provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.
Company Leadership MP
HA
KL
SL
Frequently Asked Questions Regarding Versiti Top Executives and Leadership Team
Unlock more people and company data
